Allurion Technologies【ALUR】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

2.9184

買値

売値

出来高

279,652

2.3669 日の範囲 3.2993

2.72 52 週間の範囲 98.75

時価総額

7.913M

前日終値

3.12

始値

3.12

時刻

5257

2.93

最終取引時間

財務取引量

US$ 751,068

VWAP

2.6857

平均取引量 (3 か月)

536,783

発行済株式数

2,711,263

配当利回り

PER

-0.10

1 株当たり利益 (EPS)

-30.36

歳入

53.47M

純利益

-82.3M

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient ... Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts. 詳細を表示

セクター

Blank Checks

業界

Blank Checks

本社

Wilmington, Delaware, USA

設立

Allurion Technologies Inc is listed in the Blank Checks sector of the ニューヨーク証券取引所 with ticker ALUR. The last closing price for Allurion Technologies was US$3.12. Over the last year, Allurion Technologies shares have traded in a share price range of US$ 2.72 to US$ 98.75.

Allurion Technologies currently has 2,711,263 shares in issue. The market capitalisation of Allurion Technologies is US$8.46 million. Allurion Technologies has a price to earnings ratio (PE ratio) of -0.10.

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a subscription agreement with funds...

Allurion Announces Positive Topline Results From AUDACITY Trial

At 48 weeks, Allurion Balloon subjects had a greater than 50% responder rate and substantially greater weight loss than Control subjects Low rate of serious adverse events supports favorable...

Allurion Technologies, Inc. Announces Reverse Stock Split

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that its Board of Directors has determined to effect a...

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it received an Acceptance Letter from the Listings Operations Committee of the New York Stock...

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

AllurionMeds is designed to address a critical demand from patients: The Weight Must Stay Off Features Coach Iris, a first-of-its-kind conversational AI behavioral agent for weight loss and...

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced its financial results for the third quarter ended September 30, 2024...

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference

19,428 patients treated with the Allurion Program across 72 countries lost an average of 12.2% of total body weight Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending...

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it will report financial results for the third quarter 2024 on...

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the submission of the first three modules of its premarket approval application (PMA) to the U.S...

Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

In a study of 167 patients, average weight reduction was 15.7% at four months, 17.1% at six months, and 14.7% at one year Body fat percentage decreased at six months with no change in muscle...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-4.6416	-61.3968253968	7.56	7.56	2.72	218530	3.32581991	CS
4	-4.9591	-62.9527134243	7.8775	13.75	2.72	466527	9.3138745	CS
12	-15.8316	-84.4352	18.75	20	2.72	536783	9.95476526	CS
26	-21.5816	-88.0881632653	24.5	25	2.72	337319	12.15689882	CS
52	-82.0816	-96.5665882353	85	98.75	2.72	734771	54.62539681	CS
156	-222.0816	-98.7029333333	225	225	2.72	530889	57.91721022	CS
260	-222.0816	-98.7029333333	225	225	2.72	530889	57.91721022	CS

ALUR - Frequently Asked Questions (FAQ)

What is the current Allurion Technologies share price?

The current share price of Allurion Technologies is US$ 2.9184

How many Allurion Technologies shares are in issue?

Allurion Technologies has 2,711,263 shares in issue

What is the market cap of Allurion Technologies?

The market capitalisation of Allurion Technologies is USD 8.46M

What is the 1 year trading range for Allurion Technologies share price?

Allurion Technologies has traded in the range of US$ 2.72 to US$ 98.75 during the past year

What is the PE ratio of Allurion Technologies?

The price to earnings ratio of Allurion Technologies is -0.1

What is the cash to sales ratio of Allurion Technologies?

The cash to sales ratio of Allurion Technologies is 0.15

What is the reporting currency for Allurion Technologies?

Allurion Technologies reports financial results in USD

What is the latest annual turnover for Allurion Technologies?

The latest annual turnover of Allurion Technologies is USD 53.47M

What is the latest annual profit for Allurion Technologies?

The latest annual profit of Allurion Technologies is USD -82.3M

What is the registered address of Allurion Technologies?

The registered address for Allurion Technologies is 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801

Which industry sector does Allurion Technologies operate in?

Allurion Technologies operates in the BLANK CHECKS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ARLAmerican Realty Investors Inc	US$ 15.93 (15.02%)	10.76k
RBOTVicarious Surgical Inc	US$ 16.382 (14.88%)	52.57k
AUNAAuna SA	US$ 8.45 (14.81%)	233.16k
MYTEMYT Netherlands Parent BV	US$ 9.45 (12.23%)	354.61k
BKSYBlackSky Technology Inc	US$ 11.71 (12.06%)	1.7M
SESSES AI Corporation	US$ 0.9369 (-9.91%)	51.58M
DMDesktop Metal Inc	US$ 2.19 (-9.88%)	547.32k
JKSJinkosolar Holdings Co Ltd	US$ 21.23 (-9.81%)	1.55M
BODIBeachbody Company Inc	US$ 6.60 (-9.59%)	19.82k
QBTSD Wave Quantum Inc	US$ 5.275 (-9.21%)	76.53M
QBTSD Wave Quantum Inc	US$ 5.275 (-9.21%)	76.53M
FFord Motor Company	US$ 10.18 (1.70%)	60.8M
BBDBanco Bradesco SA	US$ 1.96 (-1.01%)	59.92M
VALEVale SA	US$ 8.94 (1.94%)	59.4M
SESSES AI Corporation	US$ 0.9369 (-9.91%)	51.58M